Jennison Associates LLC Glycomimetics Inc Transaction History

Jennison Associates LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$10.6 - $13.12 $71,306 - $88,258	-6,727 Reduced 0.47%	1,416,738 $0
Q1 2019 May 10, 2019	BUY	$9.96 - $13.44 $13,864 - $18,708	1,392 Added 0.1%	1,423,465 $17.7 Million
Q4 2018 Feb 06, 2019	SELL	$8.47 - $14.71 $649,945 - $1.13 Million	-76,735 Reduced 5.12%	1,422,073 $13.5 Million
Q3 2018 Nov 08, 2018	SELL	$13.7 - $17.12 $1.3 Million - $1.63 Million	-95,049 Reduced 5.96%	1,498,808 $21.6 Million
Q2 2018 Aug 02, 2018	BUY	$14.63 - $19.19 $383,832 - $503,468	26,236 Added 1.67%	1,593,857 $25.7 Million
Q1 2018 Apr 20, 2018	SELL	$16.06 - $25.35 $324,813 - $512,703	-20,225 Reduced 1.27%	1,567,621 $25.4 Million
Q4 2017 Jan 25, 2018	SELL	$10.51 - $17.22 $24,761 - $40,570	-2,356 Reduced 0.15%	1,587,846 $26.7 Million
Q3 2017 Nov 03, 2017	BUY	$10.14 - $14.85 $16.1 Million - $23.6 Million	1,590,202	1,590,202 $22.2 Million

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.8M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.